These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 30043411)

  • 21. Ketogenic diet for adults in super-refractory status epilepticus.
    Thakur KT; Probasco JC; Hocker SE; Roehl K; Henry B; Kossoff EH; Kaplan PW; Geocadin RG; Hartman AL; Venkatesan A; Cervenka MC
    Neurology; 2014 Feb; 82(8):665-70. PubMed ID: 24453083
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and Safety of Ketamine in Refractory/Super-refractory Nonconvulsive Status Epilepticus: Single-Center Experience.
    Dericioglu N; Arslan D; Arsava EM; Topcuoglu MA
    Clin EEG Neurosci; 2021 Sep; 52(5):345-350. PubMed ID: 32752882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Etiology, clinical course and response to the treatment of status epilepticus in children: A 16-year single-center experience based on 602 episodes of status epilepticus.
    Kravljanac R; Djuric M; Jankovic B; Pekmezovic T
    Eur J Paediatr Neurol; 2015 Sep; 19(5):584-90. PubMed ID: 26143956
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of intravenous lorazepam dosing strategies and the incidence of refractory status epilepticus.
    Cetnarowski A; Cunningham B; Mullen C; Fowler M
    Epilepsy Res; 2023 Feb; 190():107067. PubMed ID: 36610189
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epileptic Status in a PEDiatric cohort (ESPED) requiring intensive care treatment: A multicenter, national, two-year prospective surveillance study.
    Meyer S; Langer J; Poryo M; Bay JG; Wagenpfeil S; Heinrich B; Nunold H; Strzelczyk A; Ebrahimi-Fakhari D
    Epilepsia Open; 2023 Jun; 8(2):411-424. PubMed ID: 36764666
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A "malignant" variant of status epilepticus.
    Holtkamp M; Othman J; Buchheim K; Masuhr F; Schielke E; Meierkord H
    Arch Neurol; 2005 Sep; 62(9):1428-31. PubMed ID: 16157750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Parenteral phenobarbital in status epilepticus revisited: Mayo Clinic experience.
    Hocker S; Clark S; Britton J
    Epilepsia; 2018 Oct; 59 Suppl 2():193-197. PubMed ID: 30159873
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravenous lacosamide or phenytoin for treatment of refractory status epilepticus.
    Kellinghaus C; Berning S; Stögbauer F
    Acta Neurol Scand; 2014 May; 129(5):294-9. PubMed ID: 23937330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of adjunctive perampanel for the treatment of refractory partial seizures: a pooled analysis of three phase III studies.
    Steinhoff BJ; Ben-Menachem E; Ryvlin P; Shorvon S; Kramer L; Satlin A; Squillacote D; Yang H; Zhu J; Laurenza A
    Epilepsia; 2013 Aug; 54(8):1481-9. PubMed ID: 23663001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term outcome of refractory status epilepticus in adults: A retrospective population-based study.
    Kantanen AM; Reinikainen M; Parviainen I; Kälviäinen R
    Epilepsy Res; 2017 Jul; 133():13-21. PubMed ID: 28402834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection and treatment of refractory status epilepticus in the intensive care unit.
    Drislane FW; Lopez MR; Blum AS; Schomer DL
    J Clin Neurophysiol; 2008 Aug; 25(4):181-6. PubMed ID: 18677181
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravenous levetiracetam as treatment for status epilepticus.
    Berning S; Boesebeck F; van Baalen A; Kellinghaus C
    J Neurol; 2009 Oct; 256(10):1634-42. PubMed ID: 19458986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravenous brivaracetam in status epilepticus: A retrospective single-center study.
    Kalss G; Rohracher A; Leitinger M; Pilz G; Novak HF; Neuray C; Kreidenhuber R; Höfler J; Kuchukhidze G; Trinka E
    Epilepsia; 2018 Oct; 59 Suppl 2():228-233. PubMed ID: 30043427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stiripentol for the treatment of super-refractory status epilepticus.
    Strzelczyk A; Kortland LM; Knake S; Rosenow F
    Acta Neurol Scand; 2015 Dec; 132(6):435-9. PubMed ID: 25809474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravenous Lacosamide in refractory nonconvulsive status epilepticus.
    Mnatsakanyan L; Chung JM; Tsimerinov EI; Eliashiv DS
    Seizure; 2012 Apr; 21(3):198-201. PubMed ID: 22244046
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of AMPA receptors and their antagonists in status epilepticus.
    Leo A; Giovannini G; Russo E; Meletti S
    Epilepsia; 2018 Jun; 59(6):1098-1108. PubMed ID: 29663350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Perampanel but Not Amantadine Prevents Behavioral Alterations and Epileptogenesis in Pilocarpine Rat Model of Status Epilepticus.
    Mohammad H; Sekar S; Wei Z; Moien-Afshari F; Taghibiglou C
    Mol Neurobiol; 2019 Apr; 56(4):2508-2523. PubMed ID: 30039334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Super-Refractory Status Epilepticus: Report of a Case and Review of the Literature.
    Lapenta L; Frisullo G; Vollono C; Brunetti V; Giannantoni NM; Sandroni C; Di Lella G; Della Marca G
    Clin EEG Neurosci; 2015 Oct; 46(4):335-9. PubMed ID: 25258428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Status epilepticus: Refractory and super-refractory.
    Dubey D; Kalita J; Misra UK
    Neurol India; 2017; 65(Supplement):S12-S17. PubMed ID: 28281491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomized study of intravenous valproate and phenytoin in status epilepticus.
    Agarwal P; Kumar N; Chandra R; Gupta G; Antony AR; Garg N
    Seizure; 2007 Sep; 16(6):527-32. PubMed ID: 17616473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.